Responders to four epitope peptides, p17NY9, RTVY10, NefRY11, or NefYF9, had significantly lower pVL than non-responders, while those with responses to two epitope peptides, IntIY11 or gp120TVW9, showed a trend to lower pVL than the non-responders ( Table 1 ).
← all excerpts
Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control.
1
—
—